Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States

Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Karelehto, Eveliina, Brouwer, Lieke, Benschop, Kimberley, Kok, Jen, Basile, Kerri, McMullan, Brendan, Rawlinson, William, Druce, Julian, Nicholson, Suellen, Selvarangan, Rangaraj, Harrison, Christopher, Lankachandra, Kamani, van Eijk, Hetty, Koen, Gerrit, de Jong, Menno, Pajkrt, Dasja, Wolthers, Katja C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302606/
https://www.ncbi.nlm.nih.gov/pubmed/30561318
http://dx.doi.org/10.3201/eid2501.180352
Descripción
Sumario:Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.

Ejemplares similares